Monday, March 12, 2018 6:58:22 PM
"The deal" is that the political winds are currently shifting, generic ballots are indicating that Congressional Republicans are trailing considerably behind Democrats in the 2018 polls, and Republicans will need to grab a big slice of the Independent vote that they are not currently winning in the polls, in order to maintain control over Congress
Independents often can be swung on social issues, and with each passing month, the legalization of marijuana -- particularly a state's right to legalize medical and recreational MJ without fear of federal interference -- is becoming a more important issue
If Republicans in Congress are not yet ready to back rescheduling of MJ this year (federal legalization of medical marijuana) primarily due to the big pharma lobby and social conservatism, they are still keenly aware that the majority of the electorate not only supports medical legalization to the tune of 90%, but is now also significantly in favor of legalizing recreational MJ
2018 is an election year, so the Republicans need to do something to win over these Independent pro-MJ voters and also turn out the MJ-loving Republican Libertarian vote, who may otherwise stay home on the couch in November instead of going to the polls
Legalizing hemp this summer is the answer to this political conundrum
The approval of Epidiolex (cannabis-derived CBD) by the FDA on 6/27/18 means that CBD will become unquestionably federally legal, because by law once the FDA approves a Schedule I Drug, it must be rescheduled to Schedule II or lower so it can be legally prescribed by a physician
If cannabis-derived CBD is legalized, and hemp is composed of predominantly CBD (by definition, cannot conisder a plant "Hemp" unless it contains less than 0.3% THC), then hemp is in perfect position to be federally legalized as well
Think about it this way -- if a Republican-controlled Congress won't reschedule MJ in 2018, but they want to be viewed as pro-MJ before the 2018 elections because 60%-65% of the population believes MJ should be legalized for recreational purposes, then they can pass the federal legalization of hemp through THE 2017 HEMP INDUSTRIAL FARMING ACT, and steal the pro-cannabis mantle from the Democrats
Powerful Republicans McConnell and Goodlatte are the largest backers of the federal Hemp legalization bill and 2018 is the year where the timing is right for it to pass due to the legalization of cannabis-derived CBD in June, coupled with wanting to be on the right side of the cannabis issue before the 2018 elections -- right now the Democrats own the MJ issue, but the Republicans can steal it away by taking credit for legalizing hemp
https://www.congress.gov/bill/115th-congress/house-bill/3530
http://www.roanoke.com/opinion/editorials/editorial-how-republicans-came-to-love-hemp/article_b9116c36-a706-536e-9c0c-e9f0fa3cacee.html
Here is an excerpt from the above link:
Ultimately, though, the potential for a hemp industry is constrained by those federal drug laws. That’s what Goodlatte would change. Once a hemp skeptic, he’s now convinced there’s a real economic opportunity here. Just because hemp looks like marijuana is “not sufficient to stop a whole industry from going forward,” he says. Goodlatte, significantly, is chairman of the House Judiciary Committee. Presumably, his sponsorship of the Industrial Hemp Farming Act of 2017 might allay any concerns from law-and-order legislators. Goodlatte is not exactly some back-to-the-land hippie; he’s as mainstream a Republican as there is. If the ever-cautious Goodlatte is for hemp farming, the politics of hemp really have changed.
There’s even a Trumpian “America First” argument to be made for hemp. The United States imports upwards of $600 million worth of hemp-based products each year — so American law allows hemp products, it just doesn’t make it easy for American companies to make them. Our hemp laws have the same effect as one of those “bad trade deals” that Trump likes to complain about; it stifles job creation, especially in rural areas. “That didn’t sit well with me,” Goodlatte says. He thinks it’s possible Congress could pass his bill before the 2018 mid-terms.
VATE
Sleek
Independents often can be swung on social issues, and with each passing month, the legalization of marijuana -- particularly a state's right to legalize medical and recreational MJ without fear of federal interference -- is becoming a more important issue
If Republicans in Congress are not yet ready to back rescheduling of MJ this year (federal legalization of medical marijuana) primarily due to the big pharma lobby and social conservatism, they are still keenly aware that the majority of the electorate not only supports medical legalization to the tune of 90%, but is now also significantly in favor of legalizing recreational MJ
2018 is an election year, so the Republicans need to do something to win over these Independent pro-MJ voters and also turn out the MJ-loving Republican Libertarian vote, who may otherwise stay home on the couch in November instead of going to the polls
Legalizing hemp this summer is the answer to this political conundrum
The approval of Epidiolex (cannabis-derived CBD) by the FDA on 6/27/18 means that CBD will become unquestionably federally legal, because by law once the FDA approves a Schedule I Drug, it must be rescheduled to Schedule II or lower so it can be legally prescribed by a physician
If cannabis-derived CBD is legalized, and hemp is composed of predominantly CBD (by definition, cannot conisder a plant "Hemp" unless it contains less than 0.3% THC), then hemp is in perfect position to be federally legalized as well
Think about it this way -- if a Republican-controlled Congress won't reschedule MJ in 2018, but they want to be viewed as pro-MJ before the 2018 elections because 60%-65% of the population believes MJ should be legalized for recreational purposes, then they can pass the federal legalization of hemp through THE 2017 HEMP INDUSTRIAL FARMING ACT, and steal the pro-cannabis mantle from the Democrats
Powerful Republicans McConnell and Goodlatte are the largest backers of the federal Hemp legalization bill and 2018 is the year where the timing is right for it to pass due to the legalization of cannabis-derived CBD in June, coupled with wanting to be on the right side of the cannabis issue before the 2018 elections -- right now the Democrats own the MJ issue, but the Republicans can steal it away by taking credit for legalizing hemp
https://www.congress.gov/bill/115th-congress/house-bill/3530
http://www.roanoke.com/opinion/editorials/editorial-how-republicans-came-to-love-hemp/article_b9116c36-a706-536e-9c0c-e9f0fa3cacee.html
Here is an excerpt from the above link:
Ultimately, though, the potential for a hemp industry is constrained by those federal drug laws. That’s what Goodlatte would change. Once a hemp skeptic, he’s now convinced there’s a real economic opportunity here. Just because hemp looks like marijuana is “not sufficient to stop a whole industry from going forward,” he says. Goodlatte, significantly, is chairman of the House Judiciary Committee. Presumably, his sponsorship of the Industrial Hemp Farming Act of 2017 might allay any concerns from law-and-order legislators. Goodlatte is not exactly some back-to-the-land hippie; he’s as mainstream a Republican as there is. If the ever-cautious Goodlatte is for hemp farming, the politics of hemp really have changed.
There’s even a Trumpian “America First” argument to be made for hemp. The United States imports upwards of $600 million worth of hemp-based products each year — so American law allows hemp products, it just doesn’t make it easy for American companies to make them. Our hemp laws have the same effect as one of those “bad trade deals” that Trump likes to complain about; it stifles job creation, especially in rural areas. “That didn’t sit well with me,” Goodlatte says. He thinks it’s possible Congress could pass his bill before the 2018 mid-terms.
VATE
Sleek
$LEEK$CAPE'$ GRAND SALAMI FOR 2018 MARIJUANA MANIA -- PART II
http://investorshub.advfn.com/$LEEK$CAPE$-GRAND-SALAMI-FOR-2018-MARIJUANA-MANIA-PART-II-31243/
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
